Georg Hansmann
Overview
Explore the profile of Georg Hansmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
7081
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Legchenko E, Chouvarine P, Hysko K, Qadri F, Wesolowski R, Specker E, et al.
Am J Respir Cell Mol Biol
. 2025 Feb;
PMID: 39899532
Inhaled pharmacotherapies are promising treatment options for patients with pulmonary arterial hypertension (PAH) as they minimize extrapulmonary adverse effects. Recently, we developed a highly specific inhibitor (TPHi) of the serotonin...
2.
Hysko K, Bertram H, Bobylev D, Horke A, Hansmann G
Pediatrics
. 2025 Jan;
PMID: 39761814
Coarctation of the aorta (CoA) is a potentially life-threatening congenital and obstructive anomaly of the distal aortic arch. After constriction of the ductus arteriosus, neonates may develop critical CoA in...
3.
Hopper R, Hansmann G, Hollander S, Dipchand A, van der Have O, Iler C, et al.
Circ Heart Fail
. 2024 Dec;
18(1):e000086.
PMID: 39648916
Children with left heart disease are at risk for developing pulmonary hypertension, initially secondary to pulmonary venous hypertension that can progress to include elevated pulmonary vascular resistance, known as combined...
4.
Hansmann G, Chouvarine P, Diekmann F, Giera M, Ralser M, Mulleder M, et al.
Nat Cardiovasc Res
. 2024 Aug;
1(6):568-576.
PMID: 39195868
Here we report application of human umbilical cord mesenchymal stem cell (HUCMSC)-derived therapy for pulmonary arterial hypertension (PAH). A 3-year-old female presented with heritable PAH associated with hereditary hemorrhagic telangiectasia...
5.
Legchenko E, Chouvarine P, Qadri F, Specker E, Nazare M, Wesolowski R, et al.
JACC Basic Transl Sci
. 2024 Aug;
9(7):890-902.
PMID: 39170954
The serotonin pathway has long been proposed as a promising target for pulmonary arterial hypertension (PAH)-a progressive and uncurable disease. We developed a highly specific inhibitor of the serotonin synthesizing...
6.
Voges I, Raimondi F, McMahon C, Ait-Ali L, Babu-Narayan S, Botnar R, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Jul;
25(12):e274-e294.
PMID: 38985851
Cardiovascular magnetic resonance (CMR) imaging is recommended in patients with congenital heart disease (CHD) in clinical practice guidelines as the imaging standard for a large variety of diseases. As CMR...
7.
Hysko K, Hohmann D, Bobylev D, Horke A, Bertram H, Happel C, et al.
JACC Adv
. 2024 Jun;
2(3):100326.
PMID: 38939588
Background: Critical coarctation of the aorta (CoA) is a life-threatening condition in newborns that is associated with biventricular dysfunction. Objectives: The purpose of this study was to examine clinical outcome...
8.
Hasan H, Chouvarine P, Hansmann G
JACC Adv
. 2024 Jun;
1(3):100055.
PMID: 38938394
No abstract available.
9.
Froese N, Szaroszyk M, Galuppo P, Visker J, Werlein C, Korf-Klingebiel M, et al.
J Am Heart Assoc
. 2024 Jan;
13(3):e033553.
PMID: 38293923
Background: Alveolar hypoxia is protective in the context of cardiovascular and ischemic heart disease; however, the underlying mechanisms are incompletely understood. The present study sought to test the hypothesis that...
10.
Hansmann G, Chouvarine P
J Heart Lung Transplant
. 2024 Jan;
43(5):861-862.
PMID: 38284965
No abstract available.